Analyst EPS estimates for ARS Pharmaceuticals Inc (SPRY) stock

After finishing at $8.75 in the prior trading day, ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $8.82, up 0.80%. In other words, the price has increased by $+0.07 from its previous closing price. On the day, 1960970 shares were traded. SPRY stock price reached its highest trading level at $8.96 during the session, while it also had its lowest trading level at $8.47.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.


Our goal is to gain a better understanding of SPRY by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.87 and its Current Ratio is at 21.87. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On January 31, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $10.Wedbush initiated its Outperform rating on January 31, 2023, with a $10 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 29 when Fitzpatrick Alexander A bought 46,258 shares for $3.78 per share. The transaction valued at 174,994 led to the insider holds 89,227 shares of the business.

Fitzpatrick Alexander A bought 40,000 shares of SPRY for $144,960 on Sep 28. The Chief Legal Officer now owns 42,969 shares after completing the transaction at $3.62 per share. On Sep 21, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 2,700,000 shares for $3.03 each. As a result, the insider paid 8,183,526 and bolstered with 8,556,774 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 846.70M and an Enterprise Value of 605.12M. Its current Enterprise Value per Revenue stands at 20.17k whereas that against EBITDA is -8.36.

Stock Price History:

Over the past 52 weeks, SPRY has reached a high of $9.65, while it has fallen to a 52-week low of $2.55. The 50-Day Moving Average of the stock is 6.25, while the 200-Day Moving Average is calculated to be 5.94.

Shares Statistics:

The stock has traded on average 410.70K shares per day over the past 3-months and 697.07k shares per day over the last 10 days, according to various share statistics. A total of 93.94M shares are outstanding, with a floating share count of 41.15M. Insiders hold about 57.13% of the company’s shares, while institutions hold 40.87% stake in the company. Shares short for SPRY as of Jan 31, 2024 were 4.86M with a Short Ratio of 11.84, compared to 6.97M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 5.06% and a Short% of Float of 8.16%.

Earnings Estimates

Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.17, while EPS last year was $0.77. The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.13 and low estimates of -$0.22.

Analysts are recommending an EPS of between -$0.6 and -$0.67 for the fiscal current year, implying an average EPS of -$0.64. EPS for the following year is -$0.73, with 3 analysts recommending between -$0.6 and -$0.85.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular